TriSalus Life Sciences, Inc. (TLSI)
(Delayed Data from NSDQ)
$4.90 USD
-0.02 (-0.41%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.87 -0.03 (-0.61%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TLSI 4.90 -0.02(-0.41%)
Will TLSI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TLSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TLSI
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
TLSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
Other News for TLSI
Is TLSI preparing to trend lower? 20 Day Moving Average Resistance shows up after dropping 0.41%
Is TLSI preparing to trend higher? Directional Movement Crossover Bullish shows up after rising 2.5%
TLSI forms Pocket Pivot on September 17
TLSI Crossed Above 50 Day Moving Average on September 16
50 Day Moving Average Resistance appears for TLSI after 3.84% move